Is PMOS the Same Condition I was Diagnosed with as PCOS?

A short answer for women whose diagnosis predates the rename. What stays the same, what may shift, and what you do not need to do in response to the news.

By Dr Gautam V. DaftaryDirector, Aksigen IVF

Last reviewed June 20265-minute read1,050 words

Yes. If you were diagnosed with PCOS, you have PMOS. The condition is the same. Your diagnosis has not changed; only the name has.

In May 2026, the medical community formally renamed what used to be called polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome, or PMOS¹. The change reflects two decades of research showing that the condition is more complex than the old name suggested, and that the metabolic and hormonal dimensions matter as much as the ovarian ones. The science is sound, the consensus process was rigorous, and major medical societies including the American Society for Reproductive Medicine² and the Endocrine Society³ have endorsed it.

None of that requires anything from you.

This article walks through what stays the same, what may shift in the way your care is framed, and what you should not do in response to the news.

What stays exactly the same

Your diagnosis. If you have been told you have PCOS, you have PMOS. There is no need for a new evaluation, a confirmatory test, or a fresh diagnostic conversation. The clinical criteria that established your diagnosis under the old name are the same criteria that establish it under the new name. The renaming did not change the definition of the condition.

Your medical records. The PCOS diagnosis in your file — whether made last year or fifteen years ago — continues to mean what it always meant. Over the coming years, new entries will use PMOS; old entries will continue to use PCOS. Doctors, insurance systems, and electronic health record systems are being updated to treat the two names as referring to the same condition.

Your treatment plan. Whatever combination of lifestyle changes, metformin, hormonal contraception, ovulation induction, or other intervention you are currently on continues to be the right plan. The 2023 International Guideline that drives modern clinical care⁴ has not been retracted; it has been carried forward into the PMOS framework with the same recommendations.

Your specialist team. Reproductive endocrinologists, fertility specialists, and endocrinologists who have been managing PCOS care are the same clinicians managing PMOS care. The science is unchanged; only the framing has shifted. Your doctor will not need to be re-trained to look after you.

What May Shift in Your Care

A few things may feel slightly different going forward, all of them small and most of them in the direction of more complete care, not less.

The name on your paperwork will change over time. New prescriptions, lab reports, and clinic notes will increasingly say PMOS; older documents will continue to read PCOS. This is administrative, not clinical.

The conversation at your next visit may be slightly broader. Under the old PCOS framing, the typical visit focused on cycle regulation, fertility planning, and androgen-related symptoms. Under the new PMOS framing, your clinician is more likely to ask about your weight trajectory, your cardiovascular risk factors, your sleep, your mood, and your overall metabolic profile. This is not new clinical territory — the 2023 International Guideline already recommended it — but the rename has sharpened the cue.

You may be offered tests you have not had before. If you have never had an oral glucose tolerance test, your clinician may now suggest one. If you have not had a fasting lipid profile in recent years, that may be added. If mental-health screening has not been part of your visits, it may now be introduced. These additions are not because anything is suspected to be wrong; they are because the new framework treats the metabolic and psychological dimensions as part of the diagnosis rather than as separate concerns.

What You Do Not Need to Do

Do not seek re-evaluation just because of the rename. The PCOS diagnosis you have is valid; PMOS is the same condition. Booking a fresh diagnostic visit just because of the rename is unnecessary and would not produce new clinical information.

Do not change your current medication. If you are on metformin, an oral contraceptive, an anti-androgen, or any other treatment, continue exactly as prescribed. The rename does not change indication, dosing, or duration.

Do not feel you were misdiagnosed. The PCOS diagnosis was correct under the criteria of the time. The criteria that established it remain the criteria for PMOS. The condition was always more complex than the old name suggested; the new name simply reflects that complexity more accurately.

The Rename is Not About You

The renaming of PCOS to PMOS is about the medical community catching up to what your body has been telling it. Women living with this condition have been describing the metabolic, hormonal, and emotional dimensions of it for decades; the diagnostic framework has caught up only recently. The new name reflects that catching-up, nothing more.

Whatever you have been living with, you have been living with. It has a more accurate name now, but the experience, the diagnosis, the treatment, and the team caring for you remain yours.

If anything feels uncertain about your own care in the wake of the news, bring it to your next visit. That is what the visit is for.

For the broader picture of what PMOS is and what it means clinically, see the pillar article Understanding PMOS.

About the Author

Dr Gautam V. Daftary is Director of Aksigen IVF and a senior consultant in reproductive medicine. He is a senior author on the 2026 review of PCOS / PMOS in the Indian context published in Insights in Reproductive Medicine.

This article is part of the Bharat Daftary Knowledge Centre, the patient-education programme of Aksigen IVF. It is intended for general information and does not replace consultation with a qualified clinician.

References

Teede HJ, Bahri Khomami M, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process.The Lancet. Published online May 12, 2026.
American Society for Reproductive Medicine. PCOS is Now PMOS: Understanding the Name Change. ASRM official statement, May 27, 2026.
Endocrine Society. Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide. Endocrine Society official statement, 2026.
Endocrine Society. Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide. Endocrine Society official statement, 2026.
Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, et al., on behalf of the International PCOS Network. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Human Reproduction. 2023;38(9):1655–1679.

Aksigen IVF•Bharat Daftary Knowledge Centre•Is PMOS the same condition I was diagnosed with as PCOS, v1.0•June 2026

Is PMOS the Same Condition I Was Diagnosed With as PCOS?